Eiger BioPharmaceuticals (EIGR) Reports Q2 Loss of $1.87/Share
Tweet
Share
E-mailGet Alerts EIGR Hot Sheet
Join SI Premium – FREE
Eiger BioPharmaceuticals (NASDAQ: EIGR) reported Q2 EPS of ($1.87), versus ($13.34) reported last year.
For earnings history and earnings-related data on Eiger BioPharmaceuticals (EIGR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Misses Q2 EPS by 164c
- Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
- uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
